JP2010536903A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536903A5
JP2010536903A5 JP2010522231A JP2010522231A JP2010536903A5 JP 2010536903 A5 JP2010536903 A5 JP 2010536903A5 JP 2010522231 A JP2010522231 A JP 2010522231A JP 2010522231 A JP2010522231 A JP 2010522231A JP 2010536903 A5 JP2010536903 A5 JP 2010536903A5
Authority
JP
Japan
Prior art keywords
cellulose
polymethacrylates
polyacrylates
copolymers
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010522231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536903A (ja
Filing date
Publication date
Priority claimed from DE102007041588A external-priority patent/DE102007041588A1/de
Application filed filed Critical
Publication of JP2010536903A publication Critical patent/JP2010536903A/ja
Publication of JP2010536903A5 publication Critical patent/JP2010536903A5/ja
Pending legal-status Critical Current

Links

JP2010522231A 2007-09-01 2008-08-21 酵母を含む医薬製品 Pending JP2010536903A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (2)

Publication Number Publication Date
JP2010536903A JP2010536903A (ja) 2010-12-02
JP2010536903A5 true JP2010536903A5 (enExample) 2011-04-21

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010522231A Pending JP2010536903A (ja) 2007-09-01 2008-08-21 酵母を含む医薬製品

Country Status (14)

Country Link
US (1) US20120027856A1 (enExample)
EP (1) EP2180885B1 (enExample)
JP (1) JP2010536903A (enExample)
KR (1) KR101259673B1 (enExample)
CN (1) CN101795676B (enExample)
AU (1) AU2008316051A1 (enExample)
CA (1) CA2698327C (enExample)
DE (1) DE102007041588A1 (enExample)
ES (1) ES2456267T3 (enExample)
MX (1) MX2010002167A (enExample)
NZ (1) NZ584233A (enExample)
RU (1) RU2452473C2 (enExample)
WO (1) WO2009052888A2 (enExample)
ZA (1) ZA201000853B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
US10282291B2 (en) * 2012-04-20 2019-05-07 Enmotus, Inc. Storage system with data management mechanism and method of operation thereof
WO2015190456A1 (ja) * 2014-06-10 2015-12-17 ライオン株式会社 清酒酵母を含有する錠剤
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
AU646232B2 (en) 1989-10-02 1994-02-17 Cima Labs, Inc. Effervescent dosage form and method of administering same
DK1183014T3 (da) * 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
CA2501345A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
AU2008273095A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Similar Documents

Publication Publication Date Title
JP2012515835A5 (enExample)
JP2010536903A5 (enExample)
JP2002531415A5 (enExample)
WO2007109104A3 (en) Modified release formulations containing drug-ion exchange resin complexes
RU2009117681A (ru) Комбинированный препарат для лечения сердечно-сосудистых заболеваний на основе теории хронотерапии
TW201249483A (en) Oral complex composition comprising omega-3 fatty acid ester and HMG-CoA reductase inhibitor
RU2011150228A (ru) Системы пленочного покрытия для препаратов с немедленным высвобождением, создающие усиленный барьер от влаги, и субстраты с таким покрытием
JP2009530298A5 (enExample)
PE20110583A1 (es) Comprimidos de capecitabina de disgregacion rapida
JP2019506401A5 (enExample)
PH12012502463A1 (en) Multilayer films for delivery of flavor
CA2377605A1 (en) Stable benzimidazole formulation
JP2010517591A5 (enExample)
WO2009001043A3 (en) Duloxetine formulation
CA2797812A1 (en) Enteric tablet
ITMI20000095A1 (it) Cerotto per la somministrazione locale e transdermica di principi attivi dotati di gruppi anionici ed elettronattrattori
USD643380S1 (en) Photoelectric energy transducing apparatus
CA2733299A1 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
JP2010254789A5 (enExample)
DE602006000819D1 (de) Dipyridamol enthaltende Zusammensetzungen mit verlängerter Freisetzung und Verfahren zu deren Herstellung
CA2525542A1 (en) Oral sustained release pharmaceutical composition of beraprost sodium
CN102058557A (zh) 一种多组分缓释制剂及其制备方法
WO2012014052A4 (en) Novel coated extended release pharmaceutical compositions containing paliperidone
WO2006115712A3 (en) Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
JP2015129175A5 (enExample)